BIA responds to UK Government statement on Ireland/Northern Ireland Specialised Committee 05 November 2020
Steve Bates OBE, Chief Executive of the BIA said: "The real winners from this announcement are patients in Northern Ireland. This gives patients and companies the certainty we have been asking for ahead of 31 December 2020.
"We look forward to continuing to work with the joint committee of UK Government, Northern Ireland Executive and European Union on a long-term solution to the regulation and supply of medicines to Northern Ireland as part of the UK after 2021, consistent with upholding the Good Friday Agreement and the Northern Ireland Protocol of the Withdrawal Agreement.
"We hope this announcement can be followed by a mutual recognition agreement and deal between the EU and UK. This would provide further reassurance to patients in both the EU and UK that they will continue to speedily access the fullest range of innovative medicines in the future."
Notes to Editors
1. For more information please contact Jack Fellows, Communications and Media Manager on email@example.com or 07825942934
2. For further information on the Ireland/Northern Ireland Specialised Committee meeting, please follow this link.
About the BIA
Established over 25 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative life sciences in the UK. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives.